Professor, Otolaryngology and Head and Neck Surgery, Case Western Reserve University School of Medicine
Otolaryngology (ENT)
Dr. Pierre Lavertu, MD
|
|
Give Review
Doctor Pierre Lavertu, MD is an expert in the field of Otolaryngology (ENT). He over the years received 6 awards: "America's Top Doctors", "America's Top Doctors for Cancer", "Northern Ohio Live", "Top MD", "Fellow (FACS)" and "Fellow (FAAO-HNS)". Pierre Lavertu is a published physician as well. He has 23 publications published. The latest was: A phase III randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck canc... Pierre Lavertu accepts all Medicare patients.
Publications
- Phase II study of erlotinib and docetaxel with concurrent intensity-modulated radiotherapy in locally advanced Head and neck squamous cell carcinoma.
- The use of negative pressure wound therapy with instillation in the management of cervical necrotizing fasciitis.
- A randomized phase III study of two cisplatin based chemoradiation (CCRT) regimens in locally advanced Head and neck squamous cell carcinoma (LAHNSCC): The impact of c...
- A Phase II Study of Bevacizumab in Combination with Docetaxel and Radiation in Locally Advanced Squamous Cell Carcinoma of the Head and Neck.
- A multi-institutional investigation of the prognostic value of lymph nodal yield in advanced stage Oral cavity squamous cell carcinoma (OCSCC).
- Phase II Trial of Sorafenib in Patients with Advanced Anaplastic Carcinoma of the Thyroid.
- A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome.
- A phase III randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell Head and neck canc...
- Does vocal cord fixation preclude nonsurgical management of laryngeal Cancer?
- Photodynamic therapy of cottontail rabbit papillomavirus-induced papillomas in a severe combined immunodeficient mouse xenograft system.
- Aggressive concurrent chemoradiotherapy for squamous cell head and neck Cancer: an 8-year single-institution experience.
- Mature results of a phase III randomized trial comparing concurrent chemoradiotherapy with radiation therapy alone in patients with stage III and IV squamous cell carc...
- Percutaneous trAcheotomy.
- Continuous course radiation therapy and concurrent combination chemotherapy for squamous cell head and neck Cancer.
- Maximizing local control and organ preservation in stage IV squamous cell head and neck Cancer With hyperfractionated radiation and concurrent chemotherapy.
- Giant intrathyroid parathyroid adenoma: a preoperative and intraoperative diagnostic challenge.
- Xanthogranulomatous sialadenitis: a case report and literature review.
- P53 and Ki-67 as outcome predictors for advanced squamous cell Cancers of the head and neck treated with chemoradiotherapy.
- Systemic adoptive T-cell immunotherapy in recurrent and metastatic carcinoma of the Head and neck: a phase 1 study.
- Clinical predictors of larynx preservation after multiagent concurrent chemoradiotherapy.
- Molecular classification of thyroid nodules by cytology.
- A phase IB clinical and pharmacokinetic study of the angiogenesis inhibitor SU5416 and paclitaxel in recurrent or metastatic carcinoma of the Head and neck.
Schools
University of Montreal Faculty of Medicine
University Montreal
Cleveland Clinic Foundation
Procedures Preformed
- Ablation or Excision of Nasal Turbinates
- Antrostomy and Antrotomy (Sinus Surgery)
- Diagnostic Nasal and-or Sinus Endoscopy
- Ethmoidectomy (Sinus Surgery)
- View All
Conditions Treated
- Acute Laryngitis
- Acute Sinusitis
- Bell's Palsy
- Black Eye
- View All
Doctors Specialties
- Ear, Nose, and Throat
- Otolaryngology (ENT)
Accepted Insurances
Awards
- America's Top Doctors
- America's Top Doctors for Cancer
- Northern Ohio Live
- Top MD
- Fellow (FACS)
- Fellow (FAAO-HNS)
Education
-
Cleveland Clinic Foundation -
University of Montreal Faculty of Medicine
Hospital
-
University Hospitals Case Medical Center
Drug Facts
| NPI NUMBER | 1659301943 | |
| NPPES Provider LastName | LAVERTU | |
| NPPES Provider FirstName | PIERRE | |
| NPPES Provider ZIPCode | 441061716 | |
| NPPES Provider State | OH | |
| Specialty Description | Otolaryngology | |
| Total Claim Count | 749.0 | |
| Distinct Opioid Count | 3.0 | |
| Opioid Claim Count | 63.0 | |
| Percent Opioid Claims | 8.41 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1659301943 |
| Last Name Of The Provider | LAVERTU |
| First Name Of The Provider | PIERRE |
| View All |
Similar Doctors
|
Dr. Michael S. Benninger, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Benjamin G. Wood, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Robert J. Stegmoyer, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Michael Broniatowski, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Zia R. Khan, MD |
|
|
Dr. Kyra M. Osborne, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Catherine C. Weng, MD |
|
|
Dr. Duc A. Tien, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tammy J. Wang, MD |
|
|
Dr. Heather H. Waters, MD
This Doctor is OpenDoctor Recommended.
|